We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Acute pulmonary embolism (PE) carries a high risk of morbidity and mortality and has a wide spectrum of severity, from incidental diagnosis in an asymptomatic patient to sudden refractory shock and cardiovascular collapse. Although the exact incidence remains uncertain, it is estimated that approximately 600,000 patients are diagnosed with PE annually in the United States, with mortality rates as high as 30% for patients with hemodynamic instability at presentation. A high-risk PE is one associated with hypotension or bradycardia. An intermediate-risk PE has evidence of RV strain, either by imaging or biomarkers (troponin or BNP). All others are low-risk PEs. The diagnosis of PE is often complicated by presentations that can be subtle, atypical or confounded by another coexisting disease.
This chapter discusses the diagnosis, evaluation and management of tachyarrhythmias. Ironically, the classic presentation for tachyarrhythmias mostly consists of non-specific symptoms. Patients may complain of palpitations, chest pain, lightheadedness, dyspnea, or non-specific weakness. Further evaluation will reveal a rapid heart rate on physical examination or on the electrocardiogram (ECG). Patients with unstable tachyarrhythmias present with signs and symptoms of hypoperfusion and hemodynamic compromise while still maintaining a palpable pulse. Patients who do not have a palpable pulse are deemed to be in cardiac arrest and are treated according to Advanced Cardiovascular Life Support (ACLS) guidelines. Once tachyarrhythmia is confirmed, consideration should be given to whether the arrhythmia has an underlying noncardiac etiology such as a toxic ingestion or a metabolic disturbance. The primary goal with a patient in sinus tachycardia (ST) is to treat the underlying condition rather than the tachycardia itself.